US Stock MarketDetailed Quotes

CCRN Cross Country Healthcare

Watchlist
  • 18.060
  • 0.0000.00%
Close Dec 13 16:00 ET
  • 18.020
  • -0.040-0.22%
Post 18:16 ET
582.93MMarket Cap-361.20P/E (TTM)

Cross Country Healthcare Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-89.38%7.47M
-30.90%82.4M
-87.17%6.01M
85.38%248.5M
179.49%12.07M
-50.00%70.31M
557.34%119.25M
261.39%46.87M
256.57%134.05M
105.89%4.32M
Net income from continuing operations
-80.06%2.56M
-175.19%-16.05M
-90.85%2.69M
-61.46%72.63M
-76.70%9.04M
-63.18%12.81M
-59.65%21.35M
-52.51%29.44M
42.77%188.46M
-49.99%38.79M
Operating gains losses
----
----
----
-53.78%1.72M
--0
--0
----
----
--3.73M
--1.82M
Depreciation and amortization
-0.93%4.5M
6.48%4.72M
-5.34%4.64M
45.89%18.35M
41.40%4.47M
41.26%4.54M
27.32%4.43M
80.36%4.9M
27.65%12.58M
16.25%3.16M
Deferred tax
-2.86%1.09M
-3,114.02%-3.23M
-35.51%-809K
-74.24%1.3M
-70.24%674K
264.95%1.12M
-89.79%107K
-124.59%-597K
150.99%5.06M
117.80%2.27M
Other non cash items
-26.86%463K
-30.40%435K
-21.83%444K
15.32%2.36M
-2.01%537K
-20.58%633K
302.27%625K
-43.93%568K
-51.81%2.05M
-64.71%548K
Change In working capital
-107.47%-3.43M
-11.11%75.24M
-185.29%-3.93M
220.10%127.48M
84.67%-7.63M
-51.40%45.86M
279.96%84.64M
104.44%4.61M
55.26%-106.14M
66.10%-49.76M
-Change in receivables
-105.76%-4.08M
-30.56%96.21M
74.01%13.72M
264.09%251.43M
230.42%34.2M
-19.78%70.78M
585.67%138.56M
104.22%7.89M
51.88%-153.23M
86.59%-26.23M
-Change in prepaid assets
1,416.28%1.7M
-96.07%151K
-160.51%-1.23M
103.88%268K
63.50%-2.98M
-107.77%-129K
2,789.47%3.84M
15.44%-471K
-105.56%-6.92M
-162.51%-8.15M
-Change in payables and accrued expense
98.56%-333K
67.43%-17.77M
-29.20%-15.49M
-258.84%-126.61M
-397.25%-37.02M
-364.37%-23.05M
-452.91%-54.56M
-119.04%-11.99M
-4.29%79.71M
-115.97%-7.44M
-Change in other current liabilities
53.63%-652K
26.01%-791K
27.58%-785K
11.91%-4.37M
29.08%-812K
-23.01%-1.41M
23.70%-1.07M
14.85%-1.08M
26.52%-4.96M
47.02%-1.15M
-Change in other working capital
81.58%-63K
-20.55%-2.57M
-101.46%-150K
132.60%6.76M
84.84%-1.03M
89.00%-342K
93.48%-2.13M
-53.01%10.27M
-359.67%-20.75M
-191.81%-6.8M
Cash from discontinued investing activities
Operating cash flow
-89.38%7.47M
-30.90%82.4M
-87.17%6.01M
85.38%248.5M
179.49%12.07M
-50.00%70.31M
557.34%119.25M
261.39%46.87M
256.57%134.05M
105.89%4.32M
Investing cash flow
Cash flow from continuing investing activities
67.02%-1.12M
28.70%-2.85M
36.78%-2.21M
68.60%-13.78M
92.25%-2.88M
-16.91%-3.41M
-128.08%-4M
-66.79%-3.5M
-28.87%-43.87M
-691.95%-37.11M
Net PPE purchase and sale
67.18%-1.12M
28.70%-2.85M
39.91%-2.21M
-59.05%-13.97M
-42.12%-2.88M
-17.50%-3.43M
-128.08%-4M
-75.48%-3.68M
-22.54%-8.79M
11.27%-2.02M
Net business purchase and sale
--0
--0
--0
100.57%199K
--0
--17K
--0
--182K
-30.56%-35.09M
----
Cash from discontinued investing activities
Investing cash flow
67.02%-1.12M
28.70%-2.85M
36.78%-2.21M
68.60%-13.78M
92.25%-2.88M
-16.91%-3.41M
-128.08%-4M
-66.79%-3.5M
-28.87%-43.87M
-691.95%-37.11M
Financing cash flow
Cash flow from continuing financing activities
77.61%-11.93M
86.77%-15.19M
66.47%-15.65M
-152.56%-221.24M
-205.61%-6.42M
50.52%-53.27M
-563.19%-114.87M
-249.10%-46.68M
-173.55%-87.6M
-92.23%6.08M
Net issuance payments of debt
--0
--0
--0
-327.28%-150.68M
--0
59.10%-31M
-562.15%-109.28M
-126.37%-10.4M
-127.62%-35.26M
-77.93%17.6M
Net common stock issuance
19.28%-11.92M
-216.43%-14.95M
79.95%-6.37M
-63.40%-57.65M
41.46%-6.4M
39.35%-14.77M
---4.72M
---31.76M
---35.29M
---10.94M
Net other financing activities
99.92%-6K
71.59%-248K
-105.37%-9.29M
24.27%-12.91M
97.79%-13K
0.11%-7.51M
-6.72%-873K
44.40%-4.52M
-98.65%-17.05M
61.74%-588K
Cash from discontinued financing activities
Financing cash flow
77.61%-11.93M
86.77%-15.19M
66.47%-15.65M
-152.56%-221.24M
-205.61%-6.42M
50.52%-53.27M
-563.19%-114.87M
-249.10%-46.68M
-173.55%-87.6M
-92.23%6.08M
Net cash flow
Beginning cash position
10,241.90%69.6M
1,701.37%5.24M
374.31%17.09M
247.88%3.6M
-52.83%14.3M
141.22%673K
-75.91%291K
247.88%3.6M
-35.25%1.04M
3,500.95%30.32M
Current changes in cash
-140.94%-5.58M
16,792.13%64.36M
-257.85%-11.85M
423.17%13.48M
110.42%2.78M
-54.64%13.63M
140.88%381K
-2,003.45%-3.31M
552.11%2.58M
-15,454.02%-26.72M
Effect of exchange rate changes
--0
--0
--0
188.89%8K
--10K
80.00%-2K
-66.67%1K
50.00%-1K
-250.00%-9K
--0
End cash Position
347.67%64.02M
10,241.90%69.6M
1,701.37%5.24M
374.31%17.09M
374.31%17.09M
-52.83%14.3M
141.22%673K
-75.91%291K
247.88%3.6M
247.88%3.6M
Free cash flow
-90.51%6.35M
-30.98%79.55M
-91.20%3.8M
87.22%234.52M
300.48%9.2M
-51.43%66.89M
603.23%115.25M
238.71%43.19M
235.00%125.26M
103.04%2.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -89.38%7.47M-30.90%82.4M-87.17%6.01M85.38%248.5M179.49%12.07M-50.00%70.31M557.34%119.25M261.39%46.87M256.57%134.05M105.89%4.32M
Net income from continuing operations -80.06%2.56M-175.19%-16.05M-90.85%2.69M-61.46%72.63M-76.70%9.04M-63.18%12.81M-59.65%21.35M-52.51%29.44M42.77%188.46M-49.99%38.79M
Operating gains losses -------------53.78%1.72M--0--0----------3.73M--1.82M
Depreciation and amortization -0.93%4.5M6.48%4.72M-5.34%4.64M45.89%18.35M41.40%4.47M41.26%4.54M27.32%4.43M80.36%4.9M27.65%12.58M16.25%3.16M
Deferred tax -2.86%1.09M-3,114.02%-3.23M-35.51%-809K-74.24%1.3M-70.24%674K264.95%1.12M-89.79%107K-124.59%-597K150.99%5.06M117.80%2.27M
Other non cash items -26.86%463K-30.40%435K-21.83%444K15.32%2.36M-2.01%537K-20.58%633K302.27%625K-43.93%568K-51.81%2.05M-64.71%548K
Change In working capital -107.47%-3.43M-11.11%75.24M-185.29%-3.93M220.10%127.48M84.67%-7.63M-51.40%45.86M279.96%84.64M104.44%4.61M55.26%-106.14M66.10%-49.76M
-Change in receivables -105.76%-4.08M-30.56%96.21M74.01%13.72M264.09%251.43M230.42%34.2M-19.78%70.78M585.67%138.56M104.22%7.89M51.88%-153.23M86.59%-26.23M
-Change in prepaid assets 1,416.28%1.7M-96.07%151K-160.51%-1.23M103.88%268K63.50%-2.98M-107.77%-129K2,789.47%3.84M15.44%-471K-105.56%-6.92M-162.51%-8.15M
-Change in payables and accrued expense 98.56%-333K67.43%-17.77M-29.20%-15.49M-258.84%-126.61M-397.25%-37.02M-364.37%-23.05M-452.91%-54.56M-119.04%-11.99M-4.29%79.71M-115.97%-7.44M
-Change in other current liabilities 53.63%-652K26.01%-791K27.58%-785K11.91%-4.37M29.08%-812K-23.01%-1.41M23.70%-1.07M14.85%-1.08M26.52%-4.96M47.02%-1.15M
-Change in other working capital 81.58%-63K-20.55%-2.57M-101.46%-150K132.60%6.76M84.84%-1.03M89.00%-342K93.48%-2.13M-53.01%10.27M-359.67%-20.75M-191.81%-6.8M
Cash from discontinued investing activities
Operating cash flow -89.38%7.47M-30.90%82.4M-87.17%6.01M85.38%248.5M179.49%12.07M-50.00%70.31M557.34%119.25M261.39%46.87M256.57%134.05M105.89%4.32M
Investing cash flow
Cash flow from continuing investing activities 67.02%-1.12M28.70%-2.85M36.78%-2.21M68.60%-13.78M92.25%-2.88M-16.91%-3.41M-128.08%-4M-66.79%-3.5M-28.87%-43.87M-691.95%-37.11M
Net PPE purchase and sale 67.18%-1.12M28.70%-2.85M39.91%-2.21M-59.05%-13.97M-42.12%-2.88M-17.50%-3.43M-128.08%-4M-75.48%-3.68M-22.54%-8.79M11.27%-2.02M
Net business purchase and sale --0--0--0100.57%199K--0--17K--0--182K-30.56%-35.09M----
Cash from discontinued investing activities
Investing cash flow 67.02%-1.12M28.70%-2.85M36.78%-2.21M68.60%-13.78M92.25%-2.88M-16.91%-3.41M-128.08%-4M-66.79%-3.5M-28.87%-43.87M-691.95%-37.11M
Financing cash flow
Cash flow from continuing financing activities 77.61%-11.93M86.77%-15.19M66.47%-15.65M-152.56%-221.24M-205.61%-6.42M50.52%-53.27M-563.19%-114.87M-249.10%-46.68M-173.55%-87.6M-92.23%6.08M
Net issuance payments of debt --0--0--0-327.28%-150.68M--059.10%-31M-562.15%-109.28M-126.37%-10.4M-127.62%-35.26M-77.93%17.6M
Net common stock issuance 19.28%-11.92M-216.43%-14.95M79.95%-6.37M-63.40%-57.65M41.46%-6.4M39.35%-14.77M---4.72M---31.76M---35.29M---10.94M
Net other financing activities 99.92%-6K71.59%-248K-105.37%-9.29M24.27%-12.91M97.79%-13K0.11%-7.51M-6.72%-873K44.40%-4.52M-98.65%-17.05M61.74%-588K
Cash from discontinued financing activities
Financing cash flow 77.61%-11.93M86.77%-15.19M66.47%-15.65M-152.56%-221.24M-205.61%-6.42M50.52%-53.27M-563.19%-114.87M-249.10%-46.68M-173.55%-87.6M-92.23%6.08M
Net cash flow
Beginning cash position 10,241.90%69.6M1,701.37%5.24M374.31%17.09M247.88%3.6M-52.83%14.3M141.22%673K-75.91%291K247.88%3.6M-35.25%1.04M3,500.95%30.32M
Current changes in cash -140.94%-5.58M16,792.13%64.36M-257.85%-11.85M423.17%13.48M110.42%2.78M-54.64%13.63M140.88%381K-2,003.45%-3.31M552.11%2.58M-15,454.02%-26.72M
Effect of exchange rate changes --0--0--0188.89%8K--10K80.00%-2K-66.67%1K50.00%-1K-250.00%-9K--0
End cash Position 347.67%64.02M10,241.90%69.6M1,701.37%5.24M374.31%17.09M374.31%17.09M-52.83%14.3M141.22%673K-75.91%291K247.88%3.6M247.88%3.6M
Free cash flow -90.51%6.35M-30.98%79.55M-91.20%3.8M87.22%234.52M300.48%9.2M-51.43%66.89M603.23%115.25M238.71%43.19M235.00%125.26M103.04%2.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.